Stocktoria

Greenwich LifeSciences, Inc. GLSI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-25

Greenwich LifeSciences, Inc. statistics & valuation

Market cap$290.6M
Return on capital-5505.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-6.70% -17.00% -59.20% -132.70% -1916.50% -5480.50% 2019202020212022202320242025
Shares outstanding
8.5M 12.7M 13.1M 12.9M 12.8M 13.2M 14.3M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-12842.80% -6.50% -16.80% -58.10% -127.10% -425.40% -313.30% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$0.61 -$0.69 -$1.34 -$1.43 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-313.3%-425.4%-127.1%-58.1%-16.8%-6.5%-12842.8%
Return on equity-5480.5%-1916.5%-132.7%-59.2%-17.0%-6.7%253.6%
Current ratio1.061.28———27.410.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.